Form 4: Sight Sciences CFO Sells Shares for Tax Obligations

Sight Sciences Chief Financial Officer Alison Bauerlein sold 19,948 shares of common stock at $3.30 per share to cover tax liabilities from restricted stock unit vesting.

Summary

• Alison Bauerlein, Chief Financial Officer of Sight Sciences, Inc. (SGHT), reported a transaction involving the company's common stock.
• On October 2, 2025, Ms. Bauerlein disposed of 19,948 shares of common stock.
• The shares were sold at a price of $3.30 per share.
• The purpose of this sale was to cover tax liability incurred in connection with the vesting of restricted stock units.
• Following this reported transaction, Ms. Bauerlein beneficially owns 597,520 shares of Sight Sciences common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine sale of shares to cover tax obligations arising from restricted stock unit vesting, which is a common and expected practice for executives. It does not indicate a positive or negative sentiment regarding the company's performance or future prospects.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

This Form 4 filing reports a routine insider transaction for tax purposes and does not provide information directly related to broader industry trends or competitive landscape.

Comparison to Industry Standards

• This filing details a standard insider transaction for tax purposes, which is a common occurrence across all industries for executives receiving equity compensation. It does not contain information suitable for comparison to specific company or project performance benchmarks.

Related Party Transactions

• This filing reports an insider transaction by the Chief Financial Officer, which is a type of related party dealing, specifically the sale of common stock to cover tax liabilities.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, tax-related sale and not a discretionary sale indicating a change in management's view of the company's prospects.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific transaction.

Key Dates

Recommendation

The reported transaction is a routine sale of shares by the CFO to satisfy tax obligations related to the vesting of restricted stock units. This is a common practice and does not typically signal a change in the company's fundamental outlook or the executive's confidence in the company. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

SEC Form 4, Insider Transaction, Stock Sale, CFO, Sight Sciences, SGHT, Restricted Stock Units, Tax Liability, Alison Bauerlein